Euglena Co., Ltd. (2931.T)
JPY 399.0
(0.76%)
JPY 399.0
(0.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 44.39 Billion JPY | 90.59% |
| 2021 | 23.29 Billion JPY | 74.9% |
| 2020 | 13.31 Billion JPY | -4.66% |
| 2019 | 13.96 Billion JPY | -7.95% |
| 2018 | 15.17 Billion JPY | 9.27% |
| 2017 | 13.88 Billion JPY | 25.07% |
| 2016 | 11.1 Billion JPY | 87.42% |
| 2015 | 5.92 Billion JPY | 94.47% |
| 2014 | 3.04 Billion JPY | 45.62% |
| 2013 | 2.09 Billion JPY | 31.93% |
| 2012 | 1.58 Billion JPY | 35.99% |
| 2011 | 1.16 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q1 | 10.83 Billion JPY | -10.11% |
| 2023 Q3 | 11.27 Billion JPY | -5.79% |
| 2023 Q2 | 11.96 Billion JPY | 10.44% |
| 2022 Q2 | 10.76 Billion JPY | -0.55% |
| 2022 FY | 44.39 Billion JPY | 90.59% |
| 2022 Q4 | 12.05 Billion JPY | 12.13% |
| 2022 Q3 | 10.75 Billion JPY | -0.09% |
| 2022 Q1 | 10.82 Billion JPY | 0.0% |
| 2021 Q2 | 4.37 Billion JPY | 14.36% |
| 2021 Q3 | 11.17 Billion JPY | 155.44% |
| 2021 Q1 | 3.82 Billion JPY | -2.15% |
| 2021 FY | 23.29 Billion JPY | 74.9% |
| 2020 Q3 | 3.78 Billion JPY | 9.46% |
| 2020 Q2 | 3.45 Billion JPY | 20.66% |
| 2020 FY | 13.31 Billion JPY | -4.66% |
| 2020 Q4 | 3.91 Billion JPY | 3.43% |
| 2020 Q1 | 2.86 Billion JPY | -11.07% |
| 2019 Q1 | 3.48 Billion JPY | 1.62% |
| 2019 FY | 13.96 Billion JPY | -7.95% |
| 2019 Q4 | 3.21 Billion JPY | -8.61% |
| 2019 Q3 | 3.52 Billion JPY | -0.12% |
| 2019 Q2 | 3.52 Billion JPY | 1.12% |
| 2018 Q3 | 4.03 Billion JPY | 2.06% |
| 2018 Q1 | 3.72 Billion JPY | 8.11% |
| 2018 FY | 15.17 Billion JPY | 9.27% |
| 2018 Q4 | 3.43 Billion JPY | -15.02% |
| 2018 Q2 | 3.95 Billion JPY | 6.1% |
| 2017 Q1 | 3.35 Billion JPY | 2.51% |
| 2017 Q4 | 3.44 Billion JPY | -5.61% |
| 2017 FY | 13.88 Billion JPY | 25.07% |
| 2017 Q3 | 3.65 Billion JPY | 1.43% |
| 2017 Q2 | 3.6 Billion JPY | 7.39% |
| 2016 Q1 | 2.89 Billion JPY | 23.53% |
| 2016 FY | 11.1 Billion JPY | 87.42% |
| 2016 Q4 | 3.27 Billion JPY | 12.04% |
| 2016 Q3 | 2.92 Billion JPY | -1.04% |
| 2016 Q2 | 2.95 Billion JPY | 2.14% |
| 2015 Q3 | 1.8 Billion JPY | 13.77% |
| 2015 Q4 | 2.33 Billion JPY | 29.98% |
| 2015 FY | 5.92 Billion JPY | 94.47% |
| 2015 Q1 | 1.38 Billion JPY | 18.84% |
| 2015 Q2 | 1.58 Billion JPY | 14.61% |
| 2014 Q2 | 731.16 Million JPY | -2.83% |
| 2014 Q4 | 1.16 Billion JPY | 34.75% |
| 2014 Q3 | 862.05 Million JPY | 17.9% |
| 2014 Q1 | 752.45 Million JPY | 7.39% |
| 2014 FY | 3.04 Billion JPY | 45.62% |
| 2013 Q1 | 437.94 Million JPY | 12.63% |
| 2013 Q4 | 700.67 Million JPY | 0.77% |
| 2013 Q3 | 695.29 Million JPY | 22.0% |
| 2013 Q2 | 569.92 Million JPY | 30.14% |
| 2013 FY | 2.09 Billion JPY | 31.93% |
| 2012 FY | 1.58 Billion JPY | 35.99% |
| 2012 Q4 | 388.82 Million JPY | 0.0% |
| 2011 FY | 1.16 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Kitanotatsujin Corporation | 14.66 Billion JPY | -202.689% |
| BEAUTY GARAGE Inc. | 29.84 Billion JPY | -48.762% |
| Axas Holdings Co.,Ltd. | 11.71 Billion JPY | -278.813% |
| C.I. Medical Co.,Ltd. | 45.62 Billion JPY | 2.709% |
| Kao Corporation | 1532.57 Billion JPY | 97.103% |
| Niitaka Co., Ltd. | 22.73 Billion JPY | -95.223% |
| Rohto Pharmaceutical Co.,Ltd. | 270.84 Billion JPY | 83.61% |
| Shiseido Company, Limited | 973.03 Billion JPY | 95.438% |
| Lion Corporation | 402.76 Billion JPY | 88.978% |
| Mandom Corporation | 73.23 Billion JPY | 39.383% |
| Ivy Cosmetics Corporation | 2.71 Billion JPY | -1535.822% |
| Milbon Co., Ltd. | 47.76 Billion JPY | 7.057% |
| Nippon Shikizai, Inc. | 15.05 Billion JPY | -194.962% |
| Fancl Corporation | 110.88 Billion JPY | 59.964% |
| KOSÉ Corporation | 300.4 Billion JPY | 85.223% |
| Cota Co., Ltd. | 9.13 Billion JPY | -385.85% |
| HABA Laboratories,Inc. | 12.32 Billion JPY | -260.202% |
| C'bon Cosmetics Co.,Ltd. | 8.49 Billion JPY | -422.322% |
| Pola Orbis Holdings Inc. | 173.3 Billion JPY | 74.385% |
| Noevir Holdings Co., Ltd. | 62.55 Billion JPY | 29.032% |
| Adjuvant Holdings Co.,Ltd. | 4.43 Billion JPY | -900.221% |
| Almado, Inc. | 7.53 Billion JPY | -488.849% |
| I-ne CO., LTD. | 41.64 Billion JPY | -6.601% |
| Premier Anti-Aging Co., Ltd. | 20.35 Billion JPY | -118.046% |
| Liberta Co.,Ltd. | 7.08 Billion JPY | -526.315% |
| AXXZIA Inc. | 12.19 Billion JPY | -264.096% |
| S.T. Corporation | 44.47 Billion JPY | 0.18% |
| Kobayashi Pharmaceutical Co., Ltd. | 173.45 Billion JPY | 74.407% |
| Earth Corporation | 158.34 Billion JPY | 71.965% |
| Sagami Rubber Industries Co., Ltd. | 6.11 Billion JPY | -626.241% |
| Asahi Eito Holdings Co.,Ltd. | 3.51 Billion JPY | -1161.948% |
| Ya-Man Ltd. | 32.02 Billion JPY | -38.622% |
| MTG Co., Ltd. | 60.15 Billion JPY | 26.203% |
| TRANSACTION CO.,Ltd. | 25.04 Billion JPY | -77.234% |
| SHOBIDO Corporation | 20.44 Billion JPY | -117.142% |
| Artnature Inc. | 42.85 Billion JPY | -3.599% |
| Pigeon Corporation | 94.46 Billion JPY | 53.005% |
| Unicharm Corporation | 941.79 Billion JPY | 95.286% |
| Paltac Corporation | 1151.96 Billion JPY | 96.146% |
| CB GROUP MANAGEMENT Co., Ltd. | 147.28 Billion JPY | 69.86% |